16th Edition Strategic Partnerships & Portfolio Optimization for Accessible Medicines, Specialty Therapeutics, and Generic Drugs

In order to sustain a competitive advantage the manufacturers of generic drugs, biologics, biosimilars and non-branded drugs need to innovate their business models, deal structures and organizations with new ways to research, develop, formulate, commercialize and sell their products. Attending this premier marcus evans conference will permit attendees the chance to review successful alliances, innovation, partnerships, M&A activity, and portfolios at the right size, price, and mix of complexity to sustain value optimization in a domestic and international market.